Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: flexinvesting who wrote (4234)	5/8/2016 2:38:56 PM
From: jesspro	Read Replies (1) \| Respond to of 4474

Flex/Vid, AD has consolidated all his power over ariad. And yes, nobody here and perhaps in all other ariad boards are in the know of what would happen to ariad short term or long term, that I agree 100%. He, in fact, could steer this company anywhere he wants and every which way he could, now that he has control of the BOD. Knowing the potential of its drugs and its great lab, the only problem he has is getting the resources to extend the runway to finance the clinical trials. But looking at his credentials, he was a major player in the Carl Icahn enterprise not too long ago before he built his own hedge fund. The big difference then and now is that then during his tenure with Carl, it was a point and click(buy it and sell for a quick profit) strategy. With the 'now', it is quite different with VVUS and ARIA. With VVUS, he wan't able to get out and sp went downhill. With ariad, he could have doubled his money right away with cost basis of 3s/4s but I think he saw a lot of potential with its pipeline and its great lab. Now, the greed factor kicked in and he is holding toward a grand payday. I can't blame him, I'd do the same if I were him. I think that he thinks that the worst is over for aria. It's just a matter of executing his plans....jmo.